Health care startups in Nanjing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Weikaier Pharmaceutical Technology | Nanjing | Series C | $29.6M | 2026-06-02 |
| Hope Medicine | Nanjing | Series B | $18.5M | 2024-09-27 |
| IMPACT Therapeutics | Nanjing | Series D | $34.6M | 2024-11-15 |
| Tingsheng Technology | Nanjing | Series B | $13.9M | 2026-03-05 |
| Chamlion | Nanjing | Series B | $34.3M | 2023-04-19 |
| Zenshine Pharma | Nanjing | Series C | $13.7M | 2023-10-13 |
| Weiyun AI | Nanjing | Series B | $15.2M | 2021-03-30 |
| Tuge Medical Technology | Nanjing | Series B | $27.7M | 2024-04-10 |
8 rows of the CSV in 5 of its 18 columns.
- The 119 health care startups in Nanjing, China have raised $1.8B in total.
- 17 of them closed their most recent round in the last 12 months, $112.7M combined.
- The largest of those rounds is Weikaier Pharmaceutical Technology's $29.6M Series C, dated June 2026.
- The most recent is NNB Nutrition's $29.5M Series C on 13 July 2026.
- Qiming Venture Partners is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 59 companies (50%).
- 25% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (27% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 119| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
| Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 | |
| IMPACT Therapeutics | IMPACT Therapeutics develops similar drugs to treat cancer. | Biotech | Series D | $34.6M | 2024-11-15 | BioVenture, Lilly Asia Ventures, Decheng Capital +2 | 51 to 100 | 2009 | |
| Hope Medicine | Hope Medicine develops science-driven biopharmaceutical treatments in clinical development. | Health care | Series B | $18.5M | 2024-09-27 | $102.6M | Qiming Venture Partners, Sinovation Ventures, Trustbridge Partners +2 | 1 to 10 | 2018 |
| Tuge Medical Technology | Tuge Medical Technology develops and industrializes 4K endoscopic imaging equipment and digital operating rooms. | Health care | Series B | $27.7M | 2024-04-10 | $27.7M | LongRiver Investments | 101 to 250 | 2018 |
| Zenshine Pharma | Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. | Biotech | Series C | $13.7M | 2023-10-13 | $28.7M | Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 | 11 to 50 | 2018 |
| Chamlion | Chamlion provides end-to-end digital dentistry solutions based on 3D printing. | Hardware | Series B | $34.3M | 2023-04-19 | Vertex Ventures China, Zhencheng Capital, 3H Health Investment +1 | 501 to 1,000 | 2017 | |
| Weiyun AI | Weiyun AI combines medical health and artificial intelligence to manufacture clinical dental products. | Artificial intelligence | Series B | $15.2M | 2021-03-30 | AlphaX Partners | 1 to 10 | 2018 |
Table 1. Health care startups in Nanjing, China: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 119.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
| 2 | Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 |
Table 2. Health care startups in Nanjing, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 2 | 2% | 1 | Tingsheng Technology |
| 2 | Sinovation Ventures | Venture capital firm | Beijing, China | 2 | 2% | ||
| 3 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 1 | 1% | 1 | Weikaier Pharmaceutical Technology |
| 4 | Nanjing Innovation Capital Group | Venture capital firm | Nanjing, China | 1 | 1% | 1 | Weikaier Pharmaceutical Technology |
| 5 | Dyee Capital | Private equity firm | Xiamen, China | 1 | 1% | 1 | Weikaier Pharmaceutical Technology |
| 6 | China Life Private Equity Investment | Private equity firm | Beijing, China | 1 | 1% | 1 | Weikaier Pharmaceutical Technology |
| 7 | Highlight Capital | Private equity firm | Nanjin, China | 1 | 1% | ||
| 8 | Wuxi Capital | Angel group | Wuxi Shi, China | 1 | 1% | ||
| 9 | Trustbridge Partners | Private equity firm | Boston, United States | 1 | 1% | ||
| 10 | WuXi Healthcare Ventures | Venture capital firm | Cambridge, United States | 1 | 1% | ||
| 11 | Guangzhou Yuexiu Industrial Investment Fund | Corporate venture arm | Guangzhou, China | 1 | 1% | ||
| 12 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 13 | BioVenture | Venture capital firm | Suzhou, China | 1 | 1% | ||
| 14 | Decheng Capital | Venture capital firm | Menlo Park, United States | 1 | 1% | ||
| 15 | Titanium Capital | Hedge fund | North Palm Beach, United States | 1 | 1% | 1 | Tingsheng Technology |
Table 3. Health care startups in Nanjing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 59 | 50% | $1.1B |
| Hardware | 5 | 4% | $14.6M |
| Software | 5 | 4% | $485K |
| Artificial intelligence | 2 | 2% | |
| Commerce | 2 | 2% | $88.7M |
Table 4. Health care startups in Nanjing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Nanjing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 18% | |
| July 2026 | 1 | 6% | $29.5M |
| June 2026 | 1 | 6% | $29.6M |
| May 2026 | 1 | 6% | |
| March 2026 | 2 | 12% | $13.9M |
| January 2026 | 2 | 12% | $483K |
| December 2025 | 4 | 24% | $39.2M |
| November 2025 | 3 | 18% |
Table 6. Health care startups in Nanjing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 10 | 8% | $73.5M |
| 2025 | 27 | 23% | $227.2M |
| 2024 | 8 | 7% | $110.8M |
| 2023 | 21 | 18% | $152.9M |
| 2022 | 14 | 12% | $163.1M |
| 2021 | 8 | 7% | $280.5M |
Table 7. Health care startups in Nanjing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 6% |
| 2020 to 2022 | 23 | 19% |
| 2015 to 2019 | 56 | 47% |
| 2010 to 2014 | 22 | 18% |
| Before 2010 | 11 | 9% |
Table 8. Health care startups in Nanjing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 10 | 12% |
| 11 to 50 | 23 | 27% |
| 51 to 100 | 21 | 25% |
| 101 to 250 | 12 | 14% |
| 251 to 500 | 7 | 8% |
| 501 to 1,000 | 8 | 9% |
| 1,001 to 5,000 | 4 | 5% |
Table 9. Health care startups in Nanjing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Nanjing, China. On 16 November 2026 that is 119 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 119 rows: 48 have no round amount, 0 no city and 41 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Nanjing, China are on the list?
- 119, in the file dated 16 November 2026. 17 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 119 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.